Erythromycin C

CAS : 1675-02-1

Ref. 3D-AE22800

Informations sur le produit

• Nom: Erythromycin C
• Synonymes: 3''-O-Demethyl erythromycin, (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-{[(2R,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (non-preferred name), 3''-O-Demethylerythromycin, Erythromycin, 3''-O-demethyl-, Oxacyclotetradecane, erythromycin deriv.

Description

Erythromycin C is a macrolide antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It has been used in vitro to study chronic cough and as a treatment for streptococcal pharyngitis. Erythromycin C has also been shown to inhibit bacterial growth in wastewater treatment, which may be due to its ability to bind with DNA-dependent RNA polymerase and prevent transcription and replication. The biological properties of erythromycin C are similar to those of erythromycin A, but it is less effective against gram-positive bacteria. It also has anti-inflammatory effects, which may be due to its inhibition of prostaglandin synthesis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 719.9 g/mol
• Formule: C₃₆H₆₅NO₁₃
• Degré de pureté: Min. 95%